Accutane Lawsuit
Accutane lawsuit news has been a pertinent topic to families
and patients everywhere ever since the acne medication’s entrance
to world markets. Receiving FDA approval in 1982, Accutane
has been linked to deadly and serious Accutane
side effects from the start. A lucrative drug for manufacturer
Hoffmann-La Roche, an estimated five million people in the U.S.
have taken Accutane alone, making it the highest profitable drug
the company has. Roche appears to have a high number of Accutane
lawsuits to battle in the future as insider information has surfaced,
indicating the Accutane manufacturer was aware of the deadly effects
that could occur but failed to adequately inform the FDA, physicians,
and patients of them.
It took almost twenty years for Roche to put into place a safety
program to adequately warn women of the birth
defects and fetal deaths that occur when using Accutane while
pregnant even though the company knew of the serious risk of birth
defects since 1971. It was not until the FDA first recommended “active
consideration of removal of Accutane from the market” that
Roche responded. Even in 2001, research showed women were still
not receiving the message that using Accutane drastically increases
chances of birth defects.
Roche
had denied the connection between Accutane and certain psychiatric
disorders, including depression leading to suicide. After French
health officials ordered that Roche include warnings of suicide
attempts to the Accutane side effects sections in 1997, the company
failed to notify the FDA of these developments. Roche could have
chosen to warn Accutane users that suicide has been observed in
Accutane patients, however they did quite the opposite in attempts
to continue promoting the popular medication.
When the FDA told Roche to include warnings of psychiatric disorders,
including suicide on Accutane labels, the company advertised nearly
the opposite. Roche tried to use the argument that acne causes people
feelings of depression and since Accutane is used to treat acne,
Accutane was lessening feelings of depression. The FDA responded
by issuing a warning letter, finding Roche’s Accutane advertisements
to be false and misleading, in addition to being “particularly
troublesome.”
When Michigan Rep. Bart Stupak’s son committed suicide while
on Accutane, it struck a personal chord, resulting in an aggressive
attempt to gain more information on the extent of Accutane side
effects. Stupak has not yet taken any individual steps toward an
Accutane lawsuit but hopes other Accutane lawsuits will bring more
attention to the Accutane side effects to people hearing about the
Accutane legal news. Families that have suffered suicide losses
linked to Accutane have had similar stories as Stupak in that their
children failed to show any signs of depression prior to the suicide
act.
A December 11, 2002 hearing on Accutane focused on Accutane birth
defects, depression, and 173 suicides. The SMART program was designed
to prevent birth defects from occurring with women using Accutane.
Roche claimed that only 2,300 pregnancies have occurred since Accutane’s
entrance to the market, however Stupak has found that according
to a 1990 Roche Accutane report it indicated in a three-month period
alone during 1999 there were 93 unwanted pregnancies reported and
42 abortions occurred.
A 1990 FDA report stated 11,000 to 13,000 Accutane Accutane related
abortions and 900-1,1000 Accutane birth defects had been suffered.
In 2001, reports indicated that women were still ill informed of
dangers of birth defects and Accutane use and after the SMART program
was strengthened at the start of 2002, a national group that tracks
prenatal birth defects exposures says reports are showing women
are still becoming pregnant while taking Accutane.
While Roche has maintained that there is a lack of scientific evidence
showing proof of depression or suicide resulting from the use of
Accutane, a 1997 FDA memo indicates Roche agreed with the agency
that there was in fact a problem. Roche officials have denied this
memo reference. Despite any scientific evidence or not, this does
not change the fact that the FDA has confirmed 173 suicides amongst
Accutane users since 1982. Based on evidence alone, a medical officer
with the FDA back in 1998 stated that it was hard to avoid concluding
that Accutane can affect the human brain and is associated to serious
psychiatric disorders in some patients.
Due to under reporting, some people fear the actual number of Accutane
patients affected by Accutane side effects is much higher. The actual
figure of suicides associated to Accutane use could be as high as
20,000, according to an FDA official that says only 1% of suicide
adverse events are ever even reported. Now, in addition to links
between Accutane and birth defects and psychiatric disorders, reports
of possible connections between Accutane and inflammatory
bowel disease and lupus have been
made as well.
As more Accutane lawsuit news become available following the December
2002 U.S. House of Representatives Energy and Commerce Committee
Oversight and Investigation Subcommittee, the future of Accutane
will unfold. The number of Accutane lawsuits to be filed and settled
will soon tell what type of future Hoffmann-La Roche is in store
for.
More Accutane Lawsuit Articles...
October 9, 2003,
"Accutane Maker Accused of Contributing to Suicide of Teenage
Boy"
May 23, 2003,
"Accutane Sparks Worldwide Concern"
|